Stanford University: Multiple Myeloma trials

The registry lists 11 Multiple Myeloma studies with Stanford University as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 1 4Phase 2 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple MyelomaRecruitingNCT06461988Phase 2
• Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ LymphoscintigraphyCompletedNCT01314963Not applicableResults posted
• Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATGCompletedNCT00899847Phase 2Results posted
• High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple MyelomaCompletedNCT00349778Phase 2Results posted
• Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse EventsCompletedNCT05123001
• Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic CancerCompletedNCT02184533Phase 1
• Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MMCompletedNCT01114282Phase 1
• Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic CellsCompletedNCT00186316Phase 1/2
• High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple MyelomaCompletedNCT00186238Phase 2
• Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell TransplantationCompletedNCT00185757Phase 1
• Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple MyelomaCompletedNCT00185653Not applicable